Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Granin proteins</td><td class="align_center">Cg A-derived peptides</td><td class="align_center">Cg A-peptide-mediated biologic function</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Chromogranin A (Cg A)<br/>Chromogranin B (CgB)<br/>Secretogranin (Sg) II (CgC)<br/>Sg III (1B1075)<br/>Sg IV (HISL-19)<br/>Sg V (7B2)<br/>Sg VI (NESP55)<br/>VGF (Sg VII)<br/>proSAAS (SgVIII)</td><td class="align_center">Vasostatin-1 (VST I: hCgA1–76)<br/>Vasostatin-2 (VST II: hCgA1–115) Pancreastatin (PST: hCgA357–428)<br/>Catestatin (CST: hCgA352–372)<br/>Parastatin (PARA: pCgA347–419)</td><td class="align_center">Regulation of glucose balance<br/>Regulation of lipid metabolism<br/>Regulation of cardiovascular system<br/>Regulation of neurotrasmitter release<br/>Regulation of the immune system<br/>Regulation of parathormone secretion</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The granin family and biological functions mediated by Cg A-derived peptides.</div>

International Journal of Endocrinology

tab1

Table 1

Table 1: Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 